Page last updated: 2024-10-19

phosphorylcholine and Acute Liver Injury, Drug-Induced

phosphorylcholine has been researched along with Acute Liver Injury, Drug-Induced in 2 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Research Excerpts

ExcerptRelevanceReference
"Miltefosine was originally formulated and registered as a topical treatment for cutaneous cancers."6.43Development of miltefosine as an oral treatment for leishmaniasis. ( Engel, J; Sindermann, H, 2006)
"Miltefosine was originally formulated and registered as a topical treatment for cutaneous cancers."2.43Development of miltefosine as an oral treatment for leishmaniasis. ( Engel, J; Sindermann, H, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sindermann, H2
Engel, J1
Bhattacharya, SK1
Sinha, PK1
Sundar, S1
Thakur, CP1
Jha, TK1
Pandey, K1
Das, VR1
Kumar, N1
Lal, C1
Verma, N1
Singh, VP1
Ranjan, A1
Verma, RB1
Anders, G1
Ganguly, NK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Pharmacokinetics of Miltefosine in Children and Adults: Implications for the Treatment of Cutaneous Leishmaniasis in Colombia.[NCT01462500]Phase 460 participants (Actual)Interventional2011-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for phosphorylcholine and Acute Liver Injury, Drug-Induced

ArticleYear
Development of miltefosine as an oral treatment for leishmaniasis.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006, Volume: 100 Suppl 1

    Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Antineoplastic Agents; Antiprotozoal Age

2006

Trials

1 trial available for phosphorylcholine and Acute Liver Injury, Drug-Induced

ArticleYear
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.
    The Journal of infectious diseases, 2007, Aug-15, Volume: 196, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Antiprotozoal Agents; Aspartate

2007